Dechra Pharmaceuticals PLC — M&A Activity 2013

Aug 16, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8371L

Dechra Pharmaceuticals PLC

15 August 2013

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

Completion of Disposal

16 August 2013

The Board of Dechra is pleased to announce that the disposal of the Services Segment announced on 10 July 2013 has now completed.  

Enquiries:
Ian Page, Chief Executive Officer	Fiona Tooley, Director
Dechra Pharmaceuticals PLC	TooleyStreet Communications
Telephone: + 44 (0) 1606 814730	Telephone: +44 (0) 121 309 0099
www.dechra.com	Mobile: +44 (0) 778 570 3523 (FT)
	Ticker: Full Listing (Pharmaceuticals): DPH

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRGGUPWRUPWGMA